Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Randomized Controlled Study to Investigate the Safety and Tolerability of IV Ferric Carboxymaltose (FCM) vs Standard Medical Care in Treating Iron Deficiency Anemia in Chronic Kidney Disease Patients

NCT00548691 is registered in ClinicalTrials.gov with American Regent, Inc. as lead sponsor.

NCT NCT00548691
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00548691 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Randomized Controlled Study to Investigate the Safety and Tolerability of IV Ferric Carboxymaltose (FCM) vs Standard Medical Care in Treating Iron Deficiency Anemia in Chronic Kidney Disease Patients
Lead sponsor
American Regent, Inc.
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2007
Completion date
July 31, 2009
Enrollment
513 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anemia